These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36745309)

  • 1. Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients.
    Lee J; Kim AR; Kang SW; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Kim SH
    Clin Exp Med; 2023 Oct; 23(6):2265. PubMed ID: 36745309
    [No Abstract]   [Full Text] [Related]  

  • 2. Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients.
    Lee J; Kim AR; Kang SW; Chang E; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Kim SH
    Clin Exp Med; 2023 Oct; 23(6):2255-2264. PubMed ID: 36607462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR; Wilson JW; Razonable RR;
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of the immune system as a driver of the critical course of novel coronavirus disease 2019.
    Kosmaczewska A; Frydecka I
    Pol Arch Intern Med; 2020 Sep; 130(9):779-788. PubMed ID: 32627515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2.
    Morgenthau AS; Levin MA; Freeman R; Reich DL; Klang E
    Lung; 2020 Oct; 198(5):771-775. PubMed ID: 32915271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Travel-related health risks in moderately and severely immunocompromised patients: a case-control study.
    Dekkiche S; de Vallière S; D'Acremont V; Genton B
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26929155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS‑CoV‑2 spike protein‑induced host inflammatory response signature in human corneal epithelial cells.
    Zhu G; Lyu L; Yang H; Liu G; Yang S; Gu C; Wang L; Yan H; Hu M; Che C
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity and the burden of herpes zoster.
    Choi WS; Kwon SS; Lee J; Choi SM; Lee JS; Eom JS; Sohn JW; Choeng HJ
    J Med Virol; 2014 Mar; 86(3):525-30. PubMed ID: 24166660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protracted course of acute pneumonias and their prophylaxis].
    Pilipchuk VN; Tkachishin VS; Zboromirskiĭ VV; Sopina NV; Kozachok SG
    Vrach Delo; 1991 Jun; (6):86-9. PubMed ID: 1891866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of extracts of Glycerrhiza glabra L. in the correction of some indices of local nonspecific defense in patients with protracted pulmonary pneumonia].
    Karimov MM
    Lik Sprava; 2001; (5-6):123-5. PubMed ID: 11881346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 'cytokine storm'.
    Gasparello J; Marzaro G; Papi C; Gentili V; Rizzo R; Zurlo M; Scapoli C; Finotti A; Gambari R
    Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digestive system infection by SARS‑CoV‑2: Entry mechanism, clinical symptoms and expression of major receptors (Review).
    Zheng L; Zhang L; Zheng Y; An J; Wen G; Jin H; Tuo B
    Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36660939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.
    Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Karteris E; Kyrou I
    Mol Med Rep; 2020 Nov; 22(5):4221-4226. PubMed ID: 33000221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value.
    Sonnleitner ST; Dorighi J; Jansen B; Schönegger C; Gietl S; Koblmüller S; Sturmbauer C; Posch W; Walder G
    Virol J; 2021 Apr; 18(1):82. PubMed ID: 33879217
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review).
    Li YS; Ren HC; Cao JH
    Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35234272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
    Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
    Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune system function and lipid peroxidation processes in protracted forms of pneumonia].
    Efimov VV; Blazhko VI; Gladchenko AR
    Vrach Delo; 1989 Apr; (4):73-5. PubMed ID: 2756694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of community acquired adenovirus pneumonia during the 2011 community outbreak in Southern Taiwan: role of host immune response.
    Shen CF; Wang SM; Ho TS; Liu CC
    BMC Infect Dis; 2017 Mar; 17(1):196. PubMed ID: 28270104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocompromised Patients with Protracted COVID-19: a Review of "Long Persisters".
    Dioverti V; Salto-Alejandre S; Haidar G
    Curr Transplant Rep; 2022; 9(4):209-218. PubMed ID: 36407883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection.
    De Maio F; Ianiro G; Coppola G; Santopaolo F; Abbate V; Bianco DM; Del Zompo F; De Matteis G; Leo M; Nesci A; Nicoletti A; Pompili M; Cammarota G; Posteraro B; Sanguinetti M; Gasbarrini A; Ponziani FR
    Gut Pathog; 2021 Oct; 13(1):62. PubMed ID: 34656179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.